« Previous
Next »
Journal of Pediatric Surgery
Volume 40, Issue 1
, Pages 251-255
, January 2005
Results of multimodal treatment for desmoplastic small round cell tumors
References
- . The clinical approach to desmoplastic small round cell tumor. Surg. Oncol. 2000;9:77–81
- . Desmoplastic small cell tumor with multi-phenotypic differentiation. Zentralbl. Pathol. 1993;139:141–151
- Desmoplastic small round cell tumors: prognostic indicators and results of surgical management. Ann. Surg. Oncol. 1998;5:416–422
- A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet. Cytogenet. 1993;69:17–21
- . A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am. J. Surg. Pathol. 1992;16:411–416
- LINE-I element insertion at the t(11;22) translocation breakpoint of a desmoplastic small round cell tumor. Genes, Chromosomes & Cancer. 1997;18:232–239
- Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J. Clin. Oncol. 1998;16:3028–3036
- Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am. J. Surg. Pathol. 2002;26:823–835
- Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J. Clin. Oncol. 1996;14:1526–1531
- The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat. Genet. 1997;17:309–313
- A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor. Am. J. Pathol. 2003;163:2165–2172
- Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product. Oncogene. 2002;21:2009–2019
- Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemother. Pharmacol. 2004;536:482–488
- . Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor. Med. Pediatr. Oncol. 2002;39:547–551
- Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors. Cancer Res. 2001;61:4048–4054
PII: S0022-3468(04)00649-9
doi: 10.1016/j.jpedsurg.2004.09.046
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Pediatric Surgery
Volume 40, Issue 1
, Pages 251-255
, January 2005
